ME/CFS is a serious condition where extreme fatigue is the main symptom and gets worse with activity rather than better with rest. This review of scientific research shows that ME/CFS affects more women than men, likely involves problems with the immune system and muscles, and that certain talk therapies and exercise programs have shown benefit in clinical trials. Most patients improve over time, though complete recovery is rare, especially in adults.
Why It Matters
This comprehensive review provides a foundational framework for understanding ME/CFS across biological, psychological, and social dimensions, helping patients and clinicians recognize that the condition involves real physiological dysfunction rather than being purely psychological. The identification of evidence-based treatments (cognitive behavioral and exercise therapies) guides clinical practice and research priorities, while the biopsychosocial model supports more holistic patient care.
Observed Findings
Prevalence estimates range from 0.2% to above 2% depending on case definitions used
Female-to-male ratio is approximately 3:1
Severe fatigue worsened by exertion and not relieved by rest is the defining symptom
Cognitive behavioral therapy and graded exercise therapy show benefits in randomized controlled trials
Most patients experience long-term improvement, but full recovery is rare; prognosis is better in adolescents
Inferred Conclusions
ME/CFS involves disturbances across multiple physiological systems (immune, muscular, cognitive, endocrine, cardiovascular) suggesting a complex, multifactorial pathophysiology
A biopsychosocial framework is appropriate for interpreting ME/CFS etiology and perpetuation
Behavioral interventions represent evidence-based treatment options while pharmaceutical approaches have not proven beneficial
Prognostic trajectory varies by age, with adolescents showing better long-term outcomes than adults
Remaining Questions
What determines which perpetuating factors are most relevant in individual patients, and how do they interact?
What This Study Does Not Prove
This review does not establish which perpetuating factors are primary or most important in individual patients, nor does it prove that the identified dysfunctions cause ME/CFS versus being consequences of the illness. The review also does not explain why graded exercise therapy benefits some patients while potentially worsening symptoms in others, nor does it clarify which genetic polymorphisms are truly causal versus associative.